Serina Therapeutics, Inc.

General ticker "SER" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $41.7M (TTM average)

Serina Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -30.3%.

Estimated limits based on current volatility of 7.1%: low 1.67$, high 1.92$

Factors to consider:

  • Total employees count: 12 as of 2018
  • US accounted for 63.4% of revenue in the fiscal year ended 2023-12-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.67$, 4.95$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.57$, 4.56$]

Financial Metrics affecting the SER estimates:

  • Positive: with PPE of -1.3 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of -70.93 <= 0.02
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of -0.23 > -0.63
  • Positive: Interest expense per share per price, % of 0.84 <= 3.30

Similar symbols

Short-term SER quotes

Long-term SER plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.21MM $0.06MM $0.00MM
Operating Expenses $10.10MM $17.10MM $24.02MM
Operating Income $-9.89MM $-17.05MM $-24.02MM
Non-Operating Income $-4.92MM $5.84MM $4.83MM
Interest Expense $4.90MM $0.53MM $0.21MM
R&D Expense $0.73MM $7.48MM $13.15MM
Income(Loss) $-14.81MM $-11.21MM $-19.20MM
Taxes $0.00MM $0.00MM $0.02MM
Profit(Loss)* $5.27MM $-11.14MM $-19.44MM
Stockholders Equity $-32.29MM $0.64MM $-0.04MM
Assets $8.97MM $6.72MM $6.95MM
Operating Cash Flow $-2.48MM $-17.14MM $-17.95MM
Capital expenditure $0.50MM $0.02MM $0.06MM
Investing Cash Flow $-0.50MM $-0.02MM $-0.06MM
Financing Cash Flow $10.07MM $13.21MM $17.41MM
Earnings Per Share** $0.63 $-1.51 $-1.91

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.